{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:48:03Z","timestamp":1792176483004,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajog.2019.07.022","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T11:07:21Z","timestamp":1563275241000},"page":"602-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Opioids affect the fetal brain: reframing the detoxification debate"],"prefix":"10.1016","volume":"221","author":[{"given":"Steve N.","family":"Caritis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.07.022_bib1","series-title":"Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. HHS Publication No. (SMA) 18-5054","year":"2018"},{"key":"10.1016\/j.ajog.2019.07.022_bib2","series-title":"Public Policy Statement. Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids. January 18","year":"2017"},{"key":"10.1016\/j.ajog.2019.07.022_bib3","series-title":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","year":"2014"},{"key":"10.1016\/j.ajog.2019.07.022_bib4","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib6","first-page":"854","article-title":"Opioid detoxification in pregnancy","volume":"92","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib7","doi-asserted-by":"crossref","first-page":"267.e1","DOI":"10.1016\/j.ajog.2013.05.026","article-title":"The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy","volume":"209","author":"Stewart","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib8","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2016.03.015","article-title":"Detoxification from opiate drugs during pregnancy","volume":"215","author":"Bell","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajog.2019.07.022_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000289","article-title":"Medically assisted withdrawal (detoxification): considering the mother\u2013infant dyad","volume":"11","author":"Jones","year":"2017","journal-title":"Addict Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajog.2016.08.004","article-title":"Detoxification from opiates during pregnancy: additional risks","volume":"216","author":"Gleeson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajog.2016.10.003","article-title":"Opioid dependence and pregnancy: minimizing stress on the fetal brain","volume":"216","author":"McCarthy","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib14","first-page":"329","article-title":"Maternal intrauterine amine alterations in the pregnant drug addict","volume":"20","author":"Zuspan","year":"1978","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/10550887.2014.909698","article-title":"The perinatal outcome of children born to women with substance dependence detoxified in residential treatment during pregnancy","volume":"33","author":"Haabrekke","year":"2014","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.ajog.2019.07.022_bib16","first-page":"e88","article-title":"Narcotic tapering in pregnancy using long-acting morphine: an 18-month prospective cohort study in northwestern Ontario","volume":"61","author":"Dooley","year":"2015","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ajog.2019.07.022_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0038-1670680","article-title":"Opioid detoxification in pregnancy: systematic review and meta-analysis of perinatal outcomes","volume":"36","author":"Wang","year":"2019","journal-title":"Am J Perinatol"},{"issue":"suppl 1","key":"10.1016\/j.ajog.2019.07.022_bib18","first-page":"17","article-title":"Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"3","author":"Lund","year":"2012","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.ajog.2019.07.022_bib19","first-page":"89","article-title":"A\u00a0Swedish population-based study of adverse birth outcomes among pregnant women treated with buprenorphine or methadone: preliminary findings","volume":"10","author":"Wurst","year":"2016","journal-title":"Subst Abuse"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2019.07.022_bib20","first-page":"5","article-title":"Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study","volume":"9","author":"N\u00f8rgaard","year":"2015","journal-title":"Subst Abuse"},{"key":"10.1016\/j.ajog.2019.07.022_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajog.2019.07.022_bib22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/add.14192","article-title":"Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway","volume":"113","author":"Nechansk\u00e1","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2019.07.022_bib23","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/EDE.0000000000000780","article-title":"Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome","volume":"29","author":"Lemon","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2019.07.022_bib25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000002881","article-title":"Prenatal treatment and outcomes of women with opioid use disorder","volume":"132","author":"Brogly","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.022_bib26","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMra1600879","article-title":"Neonatal abstinence syndrome","volume":"375","author":"McQueen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2019.07.022_bib28","first-page":"141","article-title":"Neo-natal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"10.1016\/j.ajog.2019.07.022_bib29","first-page":"994","article-title":"Newborn infants of mothers on methadone maintenance","volume":"74","author":"Lipsitz","year":"1974","journal-title":"NY Stat J Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FTD.0b013e3181d0bd68","article-title":"Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes","volume":"32","author":"Concheiro","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ajog.2019.07.022_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.2008.156","article-title":"Correlations of maternal buprenorphine dose, buprenorphine and metabolite concentrations in meconium with neonatal outcomes","volume":"84","author":"Kacinko","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2019.07.022_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2015.07.001","article-title":"Variations in opioid receptor genes in neonatal abstinence syndrome","volume":"155","author":"Wachman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajog.2019.07.022_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.earlhumdev.2005.10.013","article-title":"Ontogeny of the human central nervous system: what is happening when?","volume":"82","author":"de Graff-Peters","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2019.07.022_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2013.12.044","article-title":"The early development of brain white matter: a review of imaging studies in fetuses, newborns and infants","volume":"276","author":"Dubois","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajog.2019.07.022_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroimage.2006.08.058","article-title":"Brain Development Cooperative Group. The NIH MRI study of normal brain development (Objective-2): newborns, infants, toddlers, and preschoolers","volume":"35","author":"Almli","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.ajog.2019.07.022_bib36","doi-asserted-by":"crossref","first-page":"173ra24","DOI":"10.1126\/scitranslmed.3004978","article-title":"Cross-hemispheric functional connectivity in the human fetal brain","volume":"5","author":"Thomason","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-3782(01)00189-X","article-title":"Neurotransmitters and neuromodulators during early human development","volume":"65","author":"Herlenius","year":"2001","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2019.07.022_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000365074","article-title":"The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination","volume":"36","author":"Vestal-Laborde","year":"2014","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.ajog.2019.07.022_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tcb.2013.07.007","article-title":"Oligodendroglia: metabolic supporters of axons","volume":"23","author":"Morrison","year":"2013","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ajog.2019.07.022_bib40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20675","article-title":"Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain","volume":"56","author":"Sanchez","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ajog.2019.07.022_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0892-0362(01)00185-4","article-title":"Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny","volume":"24","author":"Robinson","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ajog.2019.07.022_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(01)00807-X","article-title":"Perinatal opioids reduce striatal nerve growth factor content in rat striatum","volume":"414","author":"Wu","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajog.2019.07.022_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5115\/acb.2012.45.2.121","article-title":"Purkinje cells loss in off spring due to maternal morphine sulfate exposure: a morphometric study","volume":"45","author":"Golalipour","year":"2012","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.ajog.2019.07.022_bib44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neuroscience.2009.02.058","article-title":"Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis","volume":"160","author":"Wang","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajog.2019.07.022_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0028-3908(02)00030-8","article-title":"Morphine induces apoptosis of human microglia and neurons","volume":"42","author":"Hu","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajog.2019.07.022_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acdb.2014.11.001","article-title":"Brains for all the ages: structural neurodevelopment in infants and children from a life-span perspective","volume":"48","author":"Richards","year":"2015","journal-title":"Adv Child Dev Behav"},{"key":"10.1016\/j.ajog.2019.07.022_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuroimage.2005.08.017","article-title":"Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood","volume":"29","author":"Hermoye","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.ajog.2019.07.022_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/dev.20579","article-title":"Neurodevelopmental MRI brain templates for children from 2 weeks to 4 years of age","volume":"54","author":"Sanchez","year":"2012","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.ajog.2019.07.022_bib49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00952990.2016.1245312","article-title":"Gray matter abnormalities in opioid-dependent patients: a neuroimaging meta-analysis","volume":"43","author":"Wollman","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ajog.2019.07.022_bib50","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3174\/ajnr.A1957","article-title":"White matter characteristics and cognition in prenatally opiate- and polysubstance-exposed children: a diffusion tensor imaging study","volume":"31","author":"Walhovd","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ajog.2019.07.022_bib51","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.neuroimage.2007.03.070","article-title":"Volumetric cerebral characteristics of children exposed to opiates and other substances in utero [Erratum in: Neuroimage 2008;41:1514-6]","volume":"36","author":"Walhovd","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.ajog.2019.07.022_bib52","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/brain\/awq138","article-title":"Alterations in brain structure and functional connectivity in prescription opioid-dependent patients","volume":"133","author":"Upadhyay","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ajog.2019.07.022_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1369-1600.2010.00266.x","article-title":"White matter microstructure in opiate addiction","volume":"17","author":"Bora","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.ajog.2019.07.022_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nicl.2017.12.033","article-title":"Prenatal methadone exposure is associated with altered neonatal brain development","volume":"18","author":"Monnelly","year":"2017","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ajog.2019.07.022_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2012.04.008","article-title":"Neural tract development of infants born to methadone-maintained mothers","volume":"47","author":"Walhovd","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ajog.2019.07.022_bib56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/jp.2014.111","article-title":"BOB (Brains, Opioids and Babies) Collaborative group. Do maternal opioids reduce neonatal regional brain volumes? A pilot study","volume":"34","author":"Yuan","year":"2014","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2019.07.022_bib57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2009.05.038","article-title":"Dysfunctional connectivity patterns in chronic heroin users: an fMRI study","volume":"460","author":"Liu","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ajog.2019.07.022_bib58","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/pm\/pnv047","article-title":"One month of oral morphine decreases gray matter volume in the right amygdala of individuals with low back pain: confirmation of previously reported magnetic resonance imaging results","volume":"17","author":"Lin","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.earlhumdev.2017.01.009","article-title":"Brain morphology in school-aged children with prenatal opioid exposure: a structural MRI study","volume":"106-107","author":"Sirnes","year":"2017","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2019.07.022_bib60","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","article-title":"Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero","volume":"97","author":"Hytinantti","year":"2008","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.ajog.2019.07.022_bib61","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0541","article-title":"Neonatal head circumference in newborns with neonatal abstinence syndrome","volume":"143","author":"Towers","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2019.07.022_bib62","first-page":"311","article-title":"Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients","volume":"61","author":"Garrison","year":"2016","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2019.07.022_bib63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/dmcn.14117","article-title":"Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis","volume":"61","author":"Monnelly","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ajog.2019.07.022_bib64","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pediatrneurol.2014.11.008","article-title":"Child neuroanatomical, neurocognitive, and visual acuity outcomes with maternal opioid and polysubstance detoxification","volume":"52","author":"Walhovd","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ajog.2019.07.022_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrn2598-c1","article-title":"Effects of prenatal opiate exposure on brain development\u2014a call for attention","volume":"10","author":"Walhovd","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ajog.2019.07.022_bib66","doi-asserted-by":"crossref","first-page":"123.e1","DOI":"10.1016\/j.ajog.2019.02.050","article-title":"Addressing the impact of opioids on women and children","volume":"221","author":"Bianchi","year":"2019","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819309068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819309068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:28:16Z","timestamp":1757590096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819309068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0002937819309068"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.07.022","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids affect the fetal brain: reframing the detoxification debate","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}